{"entity":{"type":"insider","cik":"0001845822","url":"/insider/0001845822","json_url":"/insider/0001845822.json","name":"Ildstad Suzanne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":18,"first":"2022-08-23","last":"2023-06-14","span_basis":"filed_date"},"name_variants":[{"name":"Ildstad Suzanne","source":"filing","n_filings":18,"first_seen":"2022-08-23","last_seen":"2023-06-14"}],"transactions":[{"id":8333663,"accession":"0001209191-23-037183","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-037183","line_url":"/filing/0001209191-23-037183#line-3","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12942.0,"shares_display":"12,942","price_per_share":2.4914,"price_display":"2.49","price_state":"stated","total_value":32243.6988,"total_display":"32,243.70","total_whole":"32,244","shares_owned_after":3771392.0,"shares_owned_after_display":"3,771,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-14","scope":"insider"},{"id":8333658,"accession":"0001209191-23-037183","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-037183","line_url":"/filing/0001209191-23-037183#line-2","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14208.0,"shares_display":"14,208","price_per_share":2.5576,"price_display":"2.56","price_state":"stated","total_value":36338.3808,"total_display":"36,338.38","total_whole":"36,338","shares_owned_after":3784334.0,"shares_owned_after_display":"3,784,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":8333653,"accession":"0001209191-23-037183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037183","line_url":"/filing/0001209191-23-037183#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16870.0,"shares_display":"16,870","price_per_share":2.5919,"price_display":"2.59","price_state":"stated","total_value":43725.353,"total_display":"43,725.35","total_whole":"43,725","shares_owned_after":3798542.0,"shares_owned_after_display":"3,798,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-14","scope":"insider"},{"id":8469352,"accession":"0001209191-23-035984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-035984","line_url":"/filing/0001209191-23-035984#line-3","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25419.0,"shares_display":"25,419","price_per_share":2.4642,"price_display":"2.46","price_state":"stated","total_value":62637.4998,"total_display":"62,637.50","total_whole":"62,637","shares_owned_after":3815412.0,"shares_owned_after_display":"3,815,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-09","filed_date":"2023-06-09","scope":"insider"},{"id":8469350,"accession":"0001209191-23-035984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035984","line_url":"/filing/0001209191-23-035984#line-2","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40642.0,"shares_display":"40,642","price_per_share":2.4795,"price_display":"2.48","price_state":"stated","total_value":100771.839,"total_display":"100,771.84","total_whole":"100,772","shares_owned_after":3840831.0,"shares_owned_after_display":"3,840,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-09","scope":"insider"},{"id":8469346,"accession":"0001209191-23-035984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035984","line_url":"/filing/0001209191-23-035984#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75001.0,"shares_display":"75,001","price_per_share":2.3879,"price_display":"2.39","price_state":"stated","total_value":179094.8879,"total_display":"179,094.89","total_whole":"179,095","shares_owned_after":3881473.0,"shares_owned_after_display":"3,881,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-09","scope":"insider"},{"id":8629256,"accession":"0001209191-23-035217","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035217","line_url":"/filing/0001209191-23-035217#line-2","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25549.0,"shares_display":"25,549","price_per_share":2.5283,"price_display":"2.53","price_state":"stated","total_value":64595.5367,"total_display":"64,595.54","total_whole":"64,596","shares_owned_after":2756474.0,"shares_owned_after_display":"2,756,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-07","scope":"insider"},{"id":8629252,"accession":"0001209191-23-035217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035217","line_url":"/filing/0001209191-23-035217#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7841.0,"shares_display":"7,841","price_per_share":2.5194,"price_display":"2.52","price_state":"stated","total_value":19754.6154,"total_display":"19,754.62","total_whole":"19,755","shares_owned_after":2782023.0,"shares_owned_after_display":"2,782,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"},{"id":8112591,"accession":"0001209191-23-034287","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-034287","line_url":"/filing/0001209191-23-034287#line-2","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15818.0,"shares_display":"15,818","price_per_share":2.5045,"price_display":"2.50","price_state":"stated","total_value":39616.181,"total_display":"39,616.18","total_whole":"39,616","shares_owned_after":2789864.0,"shares_owned_after_display":"2,789,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-05","scope":"insider"},{"id":8112586,"accession":"0001209191-23-034287","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-034287","line_url":"/filing/0001209191-23-034287#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15713.0,"shares_display":"15,713","price_per_share":2.5569,"price_display":"2.56","price_state":"stated","total_value":40176.5697,"total_display":"40,176.57","total_whole":"40,177","shares_owned_after":2805682.0,"shares_owned_after_display":"2,805,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-05","scope":"insider"},{"id":7835052,"accession":"0001209191-23-025602","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-025602","line_url":"/filing/0001209191-23-025602#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15004.0,"shares_display":"15,004","price_per_share":2.3481,"price_display":"2.35","price_state":"stated","total_value":35230.8924,"total_display":"35,230.89","total_whole":"35,231","shares_owned_after":2821395.0,"shares_owned_after_display":"2,821,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-25","scope":"insider"},{"id":8393554,"accession":"0001209191-23-025040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-025040","line_url":"/filing/0001209191-23-025040#line-2","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46990.0,"shares_display":"46,990","price_per_share":2.3263,"price_display":"2.33","price_state":"stated","total_value":109312.837,"total_display":"109,312.84","total_whole":"109,313","shares_owned_after":2836399.0,"shares_owned_after_display":"2,836,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-21","scope":"insider"},{"id":8393547,"accession":"0001209191-23-025040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-025040","line_url":"/filing/0001209191-23-025040#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21753.0,"shares_display":"21,753","price_per_share":2.1632,"price_display":"2.16","price_state":"stated","total_value":47056.0896,"total_display":"47,056.09","total_whole":"47,056","shares_owned_after":2883389.0,"shares_owned_after_display":"2,883,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-19","filed_date":"2023-04-21","scope":"insider"},{"id":7968858,"accession":"0001209191-23-024771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024771","line_url":"/filing/0001209191-23-024771#line-2","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49211.0,"shares_display":"49,211","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":105803.65,"total_display":"105,803.65","total_whole":"105,804","shares_owned_after":2905142.0,"shares_owned_after_display":"2,905,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-19","scope":"insider"},{"id":7968855,"accession":"0001209191-23-024771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-024771","line_url":"/filing/0001209191-23-024771#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99771.0,"shares_display":"99,771","price_per_share":2.1402,"price_display":"2.14","price_state":"stated","total_value":213529.8942,"total_display":"213,529.89","total_whole":"213,530","shares_owned_after":2954353.0,"shares_owned_after_display":"2,954,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-19","scope":"insider"},{"id":9271946,"accession":"0001209191-23-023789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023789","line_url":"/filing/0001209191-23-023789#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10436.0,"shares_display":"10,436","price_per_share":2.0643,"price_display":"2.06","price_state":"stated","total_value":21543.0348,"total_display":"21,543.03","total_whole":"21,543","shares_owned_after":3054124.0,"shares_owned_after_display":"3,054,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-04-07","scope":"insider"},{"id":7831674,"accession":"0001209191-23-020049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-020049","line_url":"/filing/0001209191-23-020049#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10436.0,"shares_display":"10,436","price_per_share":2.0643,"price_display":"2.06","price_state":"stated","total_value":21543.0348,"total_display":"21,543.03","total_whole":"21,543","shares_owned_after":3054124.0,"shares_owned_after_display":"3,054,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-20","scope":"insider"},{"id":9271945,"accession":"0001209191-23-023787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023787","line_url":"/filing/0001209191-23-023787#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6806.0,"shares_display":"6,806","price_per_share":2.0559,"price_display":"2.06","price_state":"stated","total_value":13992.4554,"total_display":"13,992.46","total_whole":"13,992","shares_owned_after":3064560.0,"shares_owned_after_display":"3,064,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-04-07","scope":"insider"},{"id":8152330,"accession":"0001209191-23-016811","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016811","line_url":"/filing/0001209191-23-016811#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6806.0,"shares_display":"6,806","price_per_share":2.0559,"price_display":"2.06","price_state":"stated","total_value":13992.4554,"total_display":"13,992.46","total_whole":"13,992","shares_owned_after":3064560.0,"shares_owned_after_display":"3,064,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":9271944,"accession":"0001209191-23-023785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023785","line_url":"/filing/0001209191-23-023785#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29.0,"shares_display":"29","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":59.45,"total_display":"59.45","total_whole":"59","shares_owned_after":3071366.0,"shares_owned_after_display":"3,071,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-04-07","scope":"insider"},{"id":7810255,"accession":"0001209191-23-014832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-014832","line_url":"/filing/0001209191-23-014832#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29.0,"shares_display":"29","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":59.45,"total_display":"59.45","total_whole":"59","shares_owned_after":3071366.0,"shares_owned_after_display":"3,071,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":9271943,"accession":"0001209191-23-023783","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023783","line_url":"/filing/0001209191-23-023783#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":2.0529,"price_display":"2.05","price_state":"stated","total_value":7185.15,"total_display":"7,185.15","total_whole":"7,185","shares_owned_after":3071395.0,"shares_owned_after_display":"3,071,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-04-07","scope":"insider"},{"id":8214649,"accession":"0001209191-23-012257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-012257","line_url":"/filing/0001209191-23-012257#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":2.0529,"price_display":"2.05","price_state":"stated","total_value":7185.15,"total_display":"7,185.15","total_whole":"7,185","shares_owned_after":3071395.0,"shares_owned_after_display":"3,071,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-23","scope":"insider"},{"id":9271942,"accession":"0001209191-23-023778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023778","line_url":"/filing/0001209191-23-023778#line-2","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3612.0,"shares_display":"3,612","price_per_share":2.0503,"price_display":"2.05","price_state":"stated","total_value":7405.6836,"total_display":"7,405.68","total_whole":"7,406","shares_owned_after":3074895.0,"shares_owned_after_display":"3,074,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-04-07","scope":"insider"},{"id":8722676,"accession":"0001209191-23-011019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-011019","line_url":"/filing/0001209191-23-011019#line-2","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3612.0,"shares_display":"3,612","price_per_share":2.0503,"price_display":"2.05","price_state":"stated","total_value":7405.6836,"total_display":"7,405.68","total_whole":"7,406","shares_owned_after":3074895.0,"shares_owned_after_display":"3,074,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-21","scope":"insider"},{"id":9271941,"accession":"0001209191-23-023778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023778","line_url":"/filing/0001209191-23-023778#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2939.0,"shares_display":"2,939","price_per_share":2.0551,"price_display":"2.06","price_state":"stated","total_value":6039.9389,"total_display":"6,039.94","total_whole":"6,040","shares_owned_after":3078507.0,"shares_owned_after_display":"3,078,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-04-07","scope":"insider"},{"id":8722674,"accession":"0001209191-23-011019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-011019","line_url":"/filing/0001209191-23-011019#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2939.0,"shares_display":"2,939","price_per_share":2.0551,"price_display":"2.06","price_state":"stated","total_value":6039.9389,"total_display":"6,039.94","total_whole":"6,040","shares_owned_after":3078507.0,"shares_owned_after_display":"3,078,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-21","scope":"insider"},{"id":6414652,"accession":"0000899243-22-029561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-029561","line_url":"/filing/0000899243-22-029561#line-1","is_derivative":false,"issuer_cik":"0001827506","issuer_name":"Talaris Therapeutics, Inc.","issuer_ticker":"TALS","issuer_name_source":null,"issuer_url":"/issuer/0001827506","owner_cik":"0001845822","owner_name":"Ildstad Suzanne","owner_display_name":"Ildstad Suzanne","owner_url":"/insider/0001845822","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":525000.0,"shares_display":"525,000","price_per_share":2.8,"price_display":"2.80","price_state":"stated","total_value":1470000.0,"total_display":"1,470,000.00","total_whole":"1,470,000","shares_owned_after":3081446.0,"shares_owned_after_display":"3,081,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-22","filed_date":"2022-08-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001827506","name":"Talaris Therapeutics, Inc.","url":"/issuer/0001827506","role":"Director, Officer (Chief Scientific Officer)","n_filings":18,"first_seen":"2022-08-23","last_seen":"2023-06-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001845822","retrieved_at":"2026-08-27T13:18:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}